TisagenlecleucelIntervention1 paperHuman trial1LatestBlood Neoplasia·15 JanTisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasNon-randomised trial in 10 peopleBlood and immune systemPaper
Blood Neoplasia·15 JanTisagenlecleucel in combination with ibrutinib in adults with relapsed and/or refractory large B-cell lymphomasNon-randomised trial in 10 peopleBlood and immune systemPaper